Notes - Finance Income And Finance Costs

Nxera Pharma Co., Ltd. - Filing #7272710

Concept 2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
Notes - Finance income and finance costs
Components of finance income and finance costs
Finance income
Finance income
1,544,000,000 JPY
1,341,000,000 JPY
Finance costs
Interest expenses
Financial liabilities measured at amortized cost
621,000,000 JPY
673,000,000 JPY
Finance costs
783,000,000 JPY
2,495,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.